A new study by researchers at Imperial College London has estimated that the UK policy of delaying the interval between first and second COVID-19 vaccines prevented 64,000 hospital admissions and 9,400 deaths between 8th December 2020 and 13th September 2021.
The team behind the VIVALDI study has found that protection given by the COVID-19 booster against infection with the virus lasts only three months for people in care homes who have not previously been infected.
The team behind the SIREN study has estimated that COVID-19 infections among patient facing hospital workers would have been 69% higher without rapid vaccination during England’s second wave of the pandemic.
The University of Oxford has officially launched its new Pandemic Sciences Institute (PSI), which will see experts from across the University work together to protect populations from the threat of future infections.
New findings from the team behind the CLARITY IBD study have shown that a drug commonly used to treat inflammatory bowel disease is associated with lower antibody responses to COVID-19 vaccines, as well as more breakthrough infections and reinfections.
A new population-scale study from the UK Coronavirus Cancer Programme has shed light on the precise factors affecting vaccine effectiveness in people with cancer.
Research undertaken by a number of UK studies has influenced the latest advice from the Joint Committee on Vaccination and Immunisation (JCVI) to give boosters to all adults over 50 in the autumn.
New research from a team at King’s College London has found that a single dose of the Pfizer vaccine is effective in reducing the risk of COVID-19 in children.
COVID-19 vaccines give effective protection to people who are underweight, overweight, or who have obesity, according to a new study by a team led by researchers at the University of Oxford.
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced up to $30 million in funding for clinical trials of a new nanoparticle vaccine it hopes will offer protection against a range of coronaviruses that could pose a threat to human health in the future.